Profiel
Tom Shaw Le Strange is currently a Director at iCON Infrastructure LLP.
Previously, he was a Director at MiroBio Ltd. in 2022.
He graduated from the University of Cambridge in 2012 and completed his undergraduate degree at The University of Nottingham in 2008.
Actieve functies van Tom Strange
| Bedrijven | Functie | Begin |
|---|---|---|
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Private Equity Investor | 01-06-2023 |
Eerdere bekende functies van Tom Strange
| Bedrijven | Functie | Einde |
|---|---|---|
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Private Equity Investor | 01-11-2022 |
Opleiding van Tom Strange
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
















